Business
Economy
Investing
Politics

Top Posts

Thermos recalls 8.2 million bottles after stoppers eject,...

Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears

Republican state attorneys general join lawsuit to stop...

Graphic: Track U.S. and state gas prices

Could an ‘8647’ T-shirt get you in trouble?

Companies must now quickly respond to stalking warrants...

Trump signs executive order expanding access to retirement...

FCC head says agency wasn’t pressured to order...

Trump briefed on options for Iran as energy...

Big Tech earnings test record stock market rally...

Business
Economy
Investing
Politics

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024

December 20, 2024

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

next post

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

Titanium-Vanadium-Magnetite Discovery Extended over 1km

December 17, 2025

$500,000 Raised for Uranium Exploration at Munaballya Well...

October 23, 2024

Copper Price Hits All‑time High on Supply Constraints...

January 8, 2026

Tech Weekly: Micron Rises on Latest Results, Trump...

December 21, 2025

Pause in Trading

February 27, 2026

Pinnacle Silver and Gold

August 21, 2025

Sitka Drills 119.0 Metres of 1.01 g/t Gold...

November 13, 2025

3D Seismic Reprocessing Complete – Significantly Enhances Prospectivity

September 2, 2024

RETRANSMISSION: Spearmint Acquires the Sisson North Tungsten Project

February 15, 2025

Pharma Market Forecast: Top Trends for Pharma in...

January 14, 2025

Fill Out & Get More Relevant News

Your name
Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

Recent Posts

Thermos recalls 8.2 million bottles after stoppers eject, causing injury and reported vision loss
May 3, 2026
Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears
May 3, 2026
Republican state attorneys general join lawsuit to stop $6.2B local TV merger
May 2, 2026
Graphic: Track U.S. and state gas prices
May 2, 2026
Could an ‘8647’ T-shirt get you in trouble?
May 2, 2026

banner ads

Categories

Business (990)
Economy (839)
Investing (4,085)
Politics (747)

Privacy Policy
Terms & Conditions

Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2026 smarttradeinsights.com | All Rights Reserved